Acurx Pharmaceuticals, Inc. (ACXP) SEC Filings https://ir.acurxpharma.com/all-sec-filings/rss Acurx Pharmaceuticals, Inc. (ACXP) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_9b22d0cd7f16bab74f9a5bd296f9e0f2/acurxpharma/logo.png Acurx Pharmaceuticals, Inc. Logo https://ir.acurxpharma.com Equisolve Investor Relations Suite <![CDATA[S-1 - General form for registration of securities under the Securities Act of 1933]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-515-0001104659-26-054887 Mon, 04 May 26 16:13:05 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-515-0001104659-26-054887 <![CDATA[S-1 - General form for registration of securities under the Securities Act of 1933]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-511-0001104659-26-054884 Mon, 04 May 26 16:09:28 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-511-0001104659-26-054884 <![CDATA[D - Notice of Exempt Offering of Securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-510-0001736243-26-000001 Wed, 29 Apr 26 16:20:23 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-510-0001736243-26-000001 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-509-0001104659-26-046846 Wed, 22 Apr 26 16:21:45 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-509-0001104659-26-046846 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-508-0001104659-26-046844 Wed, 22 Apr 26 16:21:03 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-508-0001104659-26-046844 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-507-0001104659-26-046842 Wed, 22 Apr 26 16:20:42 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-507-0001104659-26-046842 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-506-0001104659-26-046840 Wed, 22 Apr 26 16:20:34 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-506-0001104659-26-046840 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-505-0001104659-26-046837 Wed, 22 Apr 26 16:19:26 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-505-0001104659-26-046837 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-504-0001104659-26-046836 Wed, 22 Apr 26 16:18:46 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-504-0001104659-26-046836 <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.acurxpharma.com/all-sec-filings?page=1#document-503-0001104659-26-046835 Wed, 22 Apr 26 16:18:20 -0400 https://ir.acurxpharma.com/all-sec-filings?page=1#document-503-0001104659-26-046835